Regulation of experimental autoimmune encephalomyelitis by interleukin-12

Annals of the New York Academy of Sciences

Volumn 795, Issue , 1996, Pages 216-226

  Leonard, John P ^a   Waldburger, Kristine E ^a   Goldman, Samuel J ^a  

^a PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 4; NITRIC OXIDE SYNTHASE; PROTEIN; RECOMBINANT INTERLEUKIN 12;

ADOPTIVE TRANSFER; ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; AUTOIMMUNITY; CELL TRANSFER; CENTRAL NERVOUS SYSTEM DISEASE; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE COURSE; EFFECTOR CELL; ETIOLOGY; HELPER CELL; MACROPHAGE; MOUSE; NONHUMAN; PARALYSIS; PATHOGENESIS;

EID: 0030475608     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1996.tb52671.x     Document Type: Conference Paper

References (28)

1. ALVOR, E. C., JR., M. W. KIES & A. J. SUCKLING. 1984. Experimental Allergic Encephalomyelitis: A Useful Model for Multiple Sclerosis. Alan R Liss. New York.
2. PETTINELLI, C. B., R. B. FRITZ, C-H. CHOU & D. E. MACFARLIN. 1982. Encephalitogenic activity of guinea pig myelin basic protein in the SJL mouse. J. Immunol. 129: 1209.
3. TUOHY, V. K., R. A. SOBEL & M. B. LEES. 1988. Myelin proteolipid protein induced experimental allergic encephalomyelitis: Variations of disease expression in different strains of mice. J. Immunol. 140: 1868-1873.
4. + T lymphocytes. J. Immunol. 127:1420-1423.
5. KUCHROO, V. K., C. A. MARTIN, J. M. GREER, S-T. JU, R. A. SOBEL & M. E. DORF. 1993. Cytokines and adhesion molecules contribute to the ability of myelin proteolipid protein specific T cell clones to mediate experimental allergic encephalomyelitis. J. Immunol. 151: 4371-4382.
6. MERRILL, J. E., D. H. KONO, J. CLAYTON, D. G. ANDO, D. R. HINTON & F. HOFMAN. 1992. Inflammatory leukocytes and cytokines in the peptide induced disease of experimental allergic encephalomyelitis in SJL/J and B10.PL mice. Proc. Natl. Acad. Sci. USA, 89: 574-578
7. BARON, J. L., J. A. MAORI, N. H. RUDDLE, G. HASHIM & C. A. JANEWAY, JR. 1993. Surface expression of α4 integrin by CD4 T cells is required for their entry into brain parenchyma. J. Exp. Med. 177: 57-68.
8. RACKE, M. K., A. BONOMO, D. E. SCOTT, B. CANELLA, A. LEVINE, C. S. RAINE, E. M. SHEVACH & M. ROCKEN. 1994. Cytokine induced immune deviation as a therapy for inflammatory autoimmune disease. J. Exp. Med. 180: 1961-1966.
9. KUCHROO, V. K., M. DAS, J. A. BROWN, A. M. RANGER, S. S. ZAMVIL, R. A. SOBEL, H. L. WEINER, N. NABAVI & L. H. GLIMCHER. 1995. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 development pathways: Application to autoimmune disease therapy. Cell 80: 707-718.
10. MERRILL, J. E., D. H. KONO, J. CLAYTON, D. G. ANDO, D. R. HINTON & F. M. HOFMAN. 1992. Inflammatory leukocytes and cytokines in the peptide induced disease of experimental allergic encephalomyelitis in SJL/J and BIO.PL mice. Proc. Natl. Acad. Sci. USA 89: 574-578.
11. KENNEDY, M. K., D. S. TORRANCE, K. S. PICHA & K. M. MOHLER. 1992. Analysis of cytokine mRNA expression in the central nervous system of mice with experimental autoimmune encephalomyelitis reveals that IL-10 mRNA expression correlates with recovery. J. Immunol. 149: 2496-2505.
12. ROTT, O., B. FLEISHER & E. CASH. 1994. Interleukin 10 prevents experimental allergic encephalomyelitis in rats. Eur. J. Immunol 24: 1434-1440.
13. KUCHROO, V. K., C. A. MARTIN, J. M. GREER, S-T. JU, R. A. SOBEL & M. E. DORF. 1993. Cytokines and adhesion molecules contribute to the ability of myelin proteolipid protein specific T cell clones to mediate experimental allergic encephalomyelitis. J. Immunol. 151: 4371-4382.
14. KOBAYASHI, M., L. FITZ, M. RYAN, R. R. HEWICK, S. C. CLARK, S. CHAN, R. LOUDON, F. SHERMAN, B. PERUSSIA & G. TRINCHIERI. 1989. Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biological effects on human lymphocytes. J Exp. Med. 170: 827-845.
15. WOLF, S. F., P. A. TEMPLE, M. KOBAYASHI, D. YOUNG, M. DICIG, L. LOWE, R. DZIALO, L. FITZ, C. FERENZ, R. M. HEWICK, K. KELLEHER, S. H. HERRMANN, S. C. CLARK, S. H. CHAN, G. TRINCHIERI & B. PERUSSIA. 1991. Cloning of cDNA for natural killer stimulatory factor, a heterodimeric cytokine with multiple biologic effects on T and natural killer cells. J. Immunol. 146: 3074.
16. TRINCHIERI, G. 1994. Interleukin 12: A cytokine produced by antigen presenting cells with immunoregulatory functions in the generation of T helper cells type 1 and cytotoxic lymphocytes. Blood 84: 4008-4027.
17. BRUNDA, M. J. 1994. Interleukin 12. J. Leuk. Biol. 55: 280-288.
18. WOLF, S. F., D. SIEBURTH & J. SYPEK. 1994. Interleukin 12: A key modulator of immune function. Stem Cells 12: 154-168.
19. LEONARD, J. P., K. E. WALDBURGER & S. J. GOLDMAN. 1995. Prevention of experimental autoimmune encephalomyelitis by antibodies against interleukin 12. J. Exp. Med. 181:381-386.
20. WALDBURGER, K. E., R. C. HASTINGS, R. G. SCHAUB, S. J. GOLDMAN & J. P. LEONARD. 1996. Adoptive transfer of experimental allergic encephalomyelitis after in vitro treatment with rmIL-12: Preferential expansion of INF-γ producing cells and increased expression of macrophage associated iNOS as immunomodulatory mechanisms. Am. J. Pathol. 148: 375-382.
21. MERRILL, J. E., L. J. IGNARRO, M. P. SHERMAN, J. MELINEK & T. E. LANE. 1993. Microglial cell cytotoxicity of oligodendrocytes is mediated through nitric oxide. J. Immunol. 151: 2132-2141.
22. OVADIA, H., D. LEHMANN, R. KOL-MIZRACHI & O. ABRAMSKY. 1994. Inhibition of experimental allergic encephalomyelitis by nitric oxide synthase inhibitor. Neurology 44: 466P.
23. DING, A. H., C. F. NATHAN & D. J. STUEHR. 1988. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production. J. Immunol. 141: 2407.
24. LEVINE, S. & R. SOWINSKI. 1975. The role of the adrenals in relapses of experimental allergic encephalomyelitis. Proc. Soc. Exp. Biol. Med. 149: 1032-1035.
25. HARBUZ, M. S., J. P. LEONARD, S. L. LIGHTMAN & M. L. CUZNER. 1993. Changes in hypothalamic corticotrophin releasing factor and anterior pituitary pro-opiomelanocortin mRNA during the course of EAE. J. Neuroimmunol. 45: 127-132.
26. MACPHEE, I. A., F. A. ANTONI & D. W. MASON. 1989. Spontaneous recovery of rats from experimental allergic encephalomyelitis is dependent on regulation of the immune system by endogenous adrenal corticosteroids. J. Exp. Med. 169: 431-435.
27. DUONG, T. T., J. ST. LOUIS, J. J. GILBERT, F. D. FINKELMAN & G. H. STREJAN. 1992. Effect of anti-interferon-y and anti-interleukin-2 monoclonal antibody treatment on the development of actively and passively induced experimental allergic encephalomyelitis in the SJL/J mouse. J. Neuroimmunol. 36: 105-115.
28. FERBER, I. A., S. BROCKE, C. TAYLOR-EDWARDS, W. RIDGWAY, C. DINISCO, L. STIENMAN, D. DALTON & C. GARRISON FATHMAN. 1996. Mice with a disrupted IFN-γ gene are susceptible to the induction of experimental autoimmune encephalomyelitis. J. Immunol. 156: 5-7.